RI
SCMP

Redwood Investments’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Redwood Investments’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-603,176
Closed -$6.63M – 202
2017
Q1 		$6.63M Sell
603,176
-638
-0.1% -$7.41K 0.66% 79
2016
Q4 		$8.18M Buy
+603,814
New +$8.42M 0.74% 56

Other funds holding SCMP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KAM
Krensavage Asset Management New York $263M AUM 66.99% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Redwood Investments's SCMP Position: Q2 2017 in Review

Redwood Investments sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q2 2017, closing a stake of 603,176 shares — an estimated $6.63M sold.

Redwood Investments first reported a position in SCMP in Q4 2016 and held it in 2 quarters. The position peaked at $8.18M in Q4 2016. 167 funds tracked by Wall St. Rank hold SCMP as of Q2 2017.

  • Redwood Investments reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q2 2017 after selling out during the quarter.
  • Redwood Investments sold 603,176 Sucampo Pharmaceuticals, Inc. shares in Q2 2017, an estimated $6.63M.
  • Redwood Investments first reported a position in Sucampo Pharmaceuticals, Inc. in Q4 2016 and held it in 2 quarters.
  • Redwood Investments's Sucampo Pharmaceuticals, Inc. position peaked at $8.18M in Q4 2016.
  • 167 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q2 2017.

Based on Redwood Investments's 13F filing for Q2 2017, filed 4 Aug 2017.